Drug Approval | March 03, 2022
Lupin receives USFDA approval for topical solution
The product will be manufactured at Lupin’s facility in Pithampur, India
The product will be manufactured at Lupin’s facility in Pithampur, India
Viralex is an immunomodulatory agent with broad-spectrum antiviral properties. It enhances both innate & adaptive immunity and strengthens the body's defence response to viral infections
Technology adoption helped the industry to sail through Covid-19 disruption as it understood the need to digitize, learn, and excel
Sevelamer Hydrochloride tablets, 800 mg is a generic equivalent of Renagel tablets, 800 mg
Divalproex Sodium Extended-Release tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, as monotherapy and adjunctive therapy and prophylaxis of migraine headaches
The group had witnessed healthy revenue growth as revenue stood at Rs 251.14 crore in FY21.
Therapeutic use of the product is for short term symptomatic relief of colds, chills and influenza including chesty coughs
Fitch estimates JPL's EBITDA to drop significantly in FY23 due to lower volume and narrowing of the margin to 11% (FY22 estimate: 14%).
Launching Dexamethasone, Azacitidine, Carboprost, and Atropine for the Institutional Market
The focus should be on streamlining regulations, developing new molecules, increased industry academia collaboration and tapping the potential of traditional medicines
Subscribe To Our Newsletter & Stay Updated
